Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul;84(Suppl 1):78-88.
doi: 10.1038/s41390-018-0075-z.

Application of Neonatologist Performed Echocardiography in the Assessment and Management of Neonatal Heart Failure unrelated to Congenital Heart Disease

Collaborators, Affiliations
Review

Application of Neonatologist Performed Echocardiography in the Assessment and Management of Neonatal Heart Failure unrelated to Congenital Heart Disease

Philip T Levy et al. Pediatr Res. 2018 Jul.

Abstract

Neonatal heart failure (HF) is a progressive disease caused by cardiovascular and non-cardiovascular abnormalities. The most common cause of neonatal HF is structural congenital heart disease, while neonatal cardiomyopathy represents the most common cause of HF in infants with a structurally normal heart. Neonatal cardiomyopathy is a group of diseases manifesting with various morphological and functional phenotypes that affect the heart muscle and alter cardiac performance at, or soon after birth. The clinical presentation of neonates with cardiomyopathy is varied, as are the possible causes of the condition and the severity of disease presentation. Echocardiography is the selected method of choice for diagnostic evaluation, follow-up and analysis of treatment results for cardiomyopathies in neonates. Advances in neonatal echocardiography now permit a more comprehensive assessment of cardiac performance that could not be previously achieved with conventional imaging. In this review, we discuss the current and emerging echocardiographic techniques that aid in the correct diagnostic and pathophysiological assessment of some of the most common etiologies of HF that occur in neonates with a structurally normal heart and acquired cardiomyopathy and we provide recommendations for using these techniques to optimize the management of neonate with HF.

PubMed Disclaimer

Conflict of interest statement

AEK is in receipt of an Irish Health Research Board Clinical Trials Network Grant (HRB CTN 2014-10) and an EU FP7/2007-2013 grant (agreement no. 260777, The HIP Trial). AG owned equity in Neonatal Echo Skills and has received grant support from the American Heart Association. DVL is in receipt of an EU FP7/2007-2013 (agreement no 260777 the HIP trial). ED received lecture fees and consulting fees from Chiesi Pharmaceutical. EN received grant support from Research Council of Norway and Vestfold Hospital Trust. KB received lecture fees from Chiesi Pharmaceutical. MB holds a patent, “Thermal shield for the newborn baby. SG received grant support from National Institute of Health Research, Health Technology Assessment (11/92/15), UK. SR received lecture fees for Phillips Ultrasound and GE Ultrasound. WPB has received grant support from The Netherlands Organization for Health and Development (ZonMw; grant number 843002622 and 843002608). ZM has received lecture fees from Chiesi Pharmaceutical. The remaining authors declared no competing interests.

Figures

Fig. 1
Fig. 1
Heart function during and after therapeutic hypothermia demonstrated as (a) Peak strain; (b) Peak strain rate; and (c) fractional shortening. X-axis: Day of life. Y-axis: Heart function indices. Bars are means with 95% confidence intervals. *: Significantly higher than asphyxiated neonates at day 1 and 3. ¤: Significantly higher than asphyxiated neonates on day 3 treated at normothermia. #: Significantly lower than cooled neonates at day 3 and day 4 (The bars for peak systolic strain rate from reference are estimates from segment values). Reprinted with permission.
Fig. 2
Fig. 2
Examples of Echocardiographic findings in common neonatal cardiomyopathies. Infant of diabetic mother: Hypertrophic cardiomyopathy with asymmetric septal hypertrophy. The ventricular walls are hypertrophied, the cavity is small, and ventricular function is normal or hyperkinetic. Two-dimensional echocardiogram showing septal hypertrophy in hypertrophic cardiomyopathy in the parasternal long axis view (Panel a) and the short axis view (Panel b). Arrhythmia-induced neonatal cardiomyopathy (AINC) with severely dilated cardiomyopathy with LV involvement in the apical 4-chamber view (Panel c) and the parasternal short axis view (Panel d)

Comment in

References

    1. Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63–70. - PubMed
    1. Lipshultz SE, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med. 2003;348:1647–1655. - PubMed
    1. Nugent AW, et al. The epidemiology of childhood cardiomyopathy in Australia. N. Engl. J. Med. 2003;348:1639–1646. - PubMed
    1. Maron BJ, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816. - PubMed
    1. Arola A, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am. J. Epidemiol. 1997;146:385–393. - PubMed

Publication types

MeSH terms